SCHEMBL17427347

SCHEMBL17427347

CSc1nc(=O)c(C(C)=O)n[nH]1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ KDM6B O15054 1/20 0.31
▸ KDM4A O75164 1/20 0.31
▸ KDM4D Q6B0I6 1/20 0.31
▸ HIF1AN Q9NWT6 1/20 0.31
▸ KDM2A Q9Y2K7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10854391 0.72 L3MBTL1 (0.41) —
SCHEMBL19655893 0.71 CSNK2A2 (0.33) —
SCHEMBL8407246 0.63 ALDH1A1 (0.50) —
SCHEMBL11072976 0.62 PDE5A (0.40) —
SCHEMBL14498872 0.62 — —
SCHEMBL4577350 0.62 — —
SCHEMBL11066997 0.60 MAPT (0.36) —
SCHEMBL17727039 0.60 — —
SCHEMBL12354893 0.60 ADORA3 (0.39) —
SCHEMBL12257993 0.59 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160009693-A1 HERBICIDAL COMPOUNDS SYNGENTA LIMITED (GB) 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009693-A1 HERBICIDAL COMPOUNDS DDT, HAX1, CYP4X1 KDM6B 859/4885KDM4A 1115/4885KDM4D 1114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback